SOM BIOTECH Logo (EUIPO, 02/08/2022)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark SOM BIOTECH was filed as Figurative mark on 02/08/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/14/2022.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Letters presenting some other special form of writing #Red, pink, orange #Grey
| Trademark form | Figurative mark |
| File reference | 018650684 |
| Application date | February 8, 2022 |
| Publication date | March 7, 2022 |
| Entry date | June 14, 2022 |
| Expiration date | February 8, 2032 |
Trademark owner
Baldiri Reixac, 4
08028 Barcelona
ES
08028 Barcelona
ES
Trademark representatives
Avenida de Burgos, 16D, 4ª planta
Edificio Euromor
28036 Madrid
ES
goods and services
5
Pharmaceuticals; Pharmaceutical drugs; Medicine; Pharmaceutical preparations for veterinary use; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for treating metabolic disorders; Chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for activating cellular function; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for the prevention of diseases of the respiratory system; Pharmaceutical preparations for the treatment of rare diseases; Pharmaceuticals, for use in the following fields: Treatment of hereditary diseases; Pharmaceutical preparations for the treatment of gastro-intestinal disorders; Pharmaceutical products for the treatment of infectious diseases; Pharmaceuticals, for use in the following fields: Treatment of movement disorders; Pharmaceutical preparations for use in oncology; pharmaceuticals for the treatment of immune system disease; Pharmaceuticals, for use in the following fields: Treatment of skeletal muscular diseases; Pharmaceuticals, for use in the following fields: Treatment of hormone disorders; Pharmaceuticals, for use in the following fields: Treatment of skin diseases; Pharmaceutical preparations for use in ophthalmology; Pharmaceuticals, for use in the following fields: Treatment of gynaecological diseases; Pharmaceuticals, for use in the following fields: Treatment of haematological diseases; Pharmaceuticals, for use in the following fields: Treatment of paediatric diseases; Drug delivery agents; Drug detoxifying agents; Central nervous system stimulants; Respiratory stimulants; Capsules for medicines; Cardiovascular drugs used in treating congestive heart failure (CHF); Preparations for detecting genetic predispositions for medical purposes; Reagents for use in medical genetic testing; Clinical medical reagents: Cells for medical use; Tumor suppressing agents; Tumour antigens; Biopharmaceuticals for the treatment of cancer
42
Clinical research; Biological research; Chemical technological research; Scientific research; biomedical research; research services in the fields of computation chemistry; Medical and pharmacological research services; Pharmaceutical research and development; Research and development of vaccines and medicines; Research relating to molecular sciences; Research relating to biotechnology; Genetic research; Research and development in the field of microorganisms and cells; Stem cell research; Research in the field of artificial intelligence technology; Research in relation to the following fields: artificial intelligence technology; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Drug discovery services; Implementation of preclinical trials; Clinical research; Clinical trials; Clinical research; Biotechnology testing; Providing information about the results of clinical trials for pharmaceutical products; Consultancy pertaining to pharmacology; Consultancy relating to research in the field of pharmacogenetics; Consultancy relating to pharmaceutical research and development; Chemistry consultation; Consultancy relating to biotechnology; Information on the subject of scientific research in the field of biochemistry and biotechnology; Analysis in the field of molecular biology; Laboratory analysis in the field of chemistry; Design and development of medical technology; Information technology services for the pharmaceutical and healthcare industries; Design and development of computer software for use with medical technology; Design and development in relation to the following fields: artificial intelligence technology; Drug repositioning research; Drug combination research
ID: 11018650684